All articles by RanjithKumar Dharma

ProductLife boosts drug development with IntiQuan acquisition

ProductLife Group (PLG) has announced the acquisition of IntiQuan, a Swiss firm specialising in pharmacometrics. The move enhances PLG's capabilities…
Health Canada approves Telix’s Illuccix label expansion

Health Canada has expanded the approved use of Telix Pharmaceuticals' Illuccix for patient selection in prostate-specific membrane antigen (PSMA) targeted…
OnKure and Reneo Pharmaceuticals complete merger

OnKure has announced the successful completion of its merger with Reneo Pharmaceuticals, with the combined entity set to operate under…
NUHS’s CD7 CAR-T cell therapy shows promise for leukaemia

Singapore's National University Health System (NUHS) has announced that a new cluster of differentiation (CD7) chimeric antigen receptor (CAR)-T cell…
Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo

Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment specifically targeting…

Teva and mAbxience partner to develop biosimilar candidate for oncology

Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti programmed cell death protein…
BMS receives FDA approval for Opdivo to treat NSCLC

Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults…
Resilience secures funds to enhance production of essential medicine components

National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical medicine components manufacturing. Resilience received…
ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer

ImmunoPrecise Antibodies, an AI-driven biotherapeutic research and technology company, has entered into a material transfer and evaluation agreement (MTEA) with…
Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy

Novaliq and Laboratoires Théa have announced approval from the European Commission (EC) for Vevizye (ciclosporin 0.1% eye drops solution) for…